Average Co-Inventor Count = 7.31
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (13 from 3,923 patents)
13 patents:
1. 9822092 - ArylSulfonamide-based matrix metalloprotease inhibitors
2. 9815819 - Complement pathway modulators and uses thereof
3. 9550755 - Complement pathway modulators and uses thereof
4. 9487483 - Complement pathway modulators and uses thereof
5. 9468661 - Pyrrolidine derivatives and their use as complement pathway modulators
6. 9464081 - Pyrrolidine derivatives and their use as complement pathway modulators
7. 9388199 - Pyrrolidine derivatives and their use as complement pathway modulators
8. 9085555 - Complement pathway modulators and uses thereof
9. 8975439 - Arylsulfonamide based matrix metalloprotease inhibitors
10. 8841291 - Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors
11. 8362063 - Arylsulfonamide based matrix metalloprotease inhibitors
12. 8222424 - Arylsulfonamide-based matrix metalloprotease inhibitors
13. 8093406 - Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors